The European Commission has proposed a new European bio-defence preparedness plan against COVID-19 variants called “HERA Incubator” that will bring together researchers, biotech companies, manufacturers, regulators and public authorities to monitor variants, exchange data and cooperate on adapting vaccines. The plan will focus on:

  • Detecting, analysing and adapting to virus variants;
  • Speeding up regulatory approval of vaccines, providing guidance on data requirements and facilitating the certification of new or repurposed manufacturing infrastructures; and
  • Supporting the speedy mass production of adapted or novel COVID-19 vaccines.

For more information link


Please contact us ncphealth(at) if you'd like to cooperate with European stakeholders on these actions.